About EuropaBio

 

EuropaBio is the European Association for Bioindustries and was created in 1996 to provide a voice for the biotech industry in Europe. EuropaBio's mission is to promote an innovative and dynamic biotechnology-based industry in Europe.

We represent 62 corporate and 7 associate members operating worldwide, 2 Bioregions and 19 national biotechnology associations who in turn represent some 1800 small and medium sized biotech companies in Europe. Members of EuropaBio are involved in research, development, testing, manufacturing and commercialisation of biotechnology products and processes. Our corporate members have a wide range of activities: human and animal health care, diagnostics, bio-informatics, chemicals, crop protection, agriculture, food and environmental products and services

EuropaBio also welcomes associate members such as international commercial, financial, asset management and other service-providing companies, regional biotechnology development organisations and scientific institutes. The common denominator among all our members is the use of biotechnology at any stage of research, development or manufacturing.

We stand for free and open markets and the removal of barriers to competitiveness with other areas of the world.

We are committed to an open, informed dialogue with all stakeholders about the ethical, social and economic aspects of biotechnology and its applications.

We champion the responsible use of biotechnology to ensure that its potential is fully used to the benefit of the environment and mankind.

 

What we do

EuropaBio’s primary focus is representing biotechnology in the European Union, but because of the global character of the business, we also represent our members in transatlantic and worldwide discussions.

We are actively engaged in increasing the understanding of biotechnological applications and their benefits at European level and contribute to the creation of a coherent and beneficial innovation climate for the bioindustry in Europe. 

We are devoted to repositioning the communications surrounding biotechnology by showcasing the benefits of biotech to the public through journalists, publications, on line media, events and engaging with industry stakeholders from farmers to patients.